238 related articles for article (PubMed ID: 27235863)
1. Survival analysis of veteran patients with pancreatic cancer.
Kim D; Zhu H; Nassri A; Mokdad A; Kukreja S; Polanco P; Huerta S; Ramzan Z
J Dig Dis; 2016 Jun; 17(6):399-407. PubMed ID: 27235863
[TBL] [Abstract][Full Text] [Related]
2. The impact of resection margin status and postoperative CA19-9 levels on survival and patterns of recurrence after postoperative high-dose radiotherapy with 5-FU-based concurrent chemotherapy for resectable pancreatic cancer.
Kinsella TJ; Seo Y; Willis J; Stellato TA; Siegel CT; Harpp D; Willson JK; Gibbons J; Sanabria JR; Hardacre JM; Schulak JP
Am J Clin Oncol; 2008 Oct; 31(5):446-53. PubMed ID: 18838880
[TBL] [Abstract][Full Text] [Related]
3. Elevated serum CA72-4 levels predict poor prognosis in pancreatic adenocarcinoma after intensity-modulated radiation therapy.
Liu P; Zhu Y; Liu L
Oncotarget; 2015 Apr; 6(11):9592-9. PubMed ID: 25860937
[TBL] [Abstract][Full Text] [Related]
4. CA19-9-Low&Lewis (+) pancreatic cancer: A unique subtype.
Luo G; Liu C; Guo M; Long J; Liu Z; Xiao Z; Jin K; Cheng H; Lu Y; Ni Q; Yu X
Cancer Lett; 2017 Jan; 385():46-50. PubMed ID: 27840089
[TBL] [Abstract][Full Text] [Related]
5. Survival and prognostic factors in well-differentiated pancreatic neuroendocrine tumors.
Boyar Cetinkaya R; Vatn M; Aabakken L; Bergestuen DS; Thiis-Evensen E
Scand J Gastroenterol; 2014 Jun; 49(6):734-41. PubMed ID: 24679166
[TBL] [Abstract][Full Text] [Related]
6. Follow-up after curative surgery for pancreatic ductal adenocarcinoma: asymptomatic recurrence is associated with improved survival.
Nordby T; Hugenschmidt H; Fagerland MW; Ikdahl T; Buanes T; Labori KJ
Eur J Surg Oncol; 2013 Jun; 39(6):559-66. PubMed ID: 23498362
[TBL] [Abstract][Full Text] [Related]
7. Pre-treatment carbohydrate antigen 19-9 does not predict the response to neoadjuvant therapy in patients with localized pancreatic cancer.
Aldakkak M; Christians KK; Krepline AN; George B; Ritch PS; Erickson BA; Johnston FM; Evans DB; Tsai S
HPB (Oxford); 2015 Oct; 17(10):942-52. PubMed ID: 26255895
[TBL] [Abstract][Full Text] [Related]
8. [Value of combined therapy in pancreatic cancer with a poor prognosis: analysis of 233 clinical cases].
Wang Y; Zhao P; Wang CF; Shan Y; Zhao DB; Tian YT; Sun YM; Che X; Zhang JW
Zhonghua Yi Xue Za Zhi; 2009 Sep; 89(34):2381-5. PubMed ID: 20137689
[TBL] [Abstract][Full Text] [Related]
9. Predictive Value of Serum Carbohydrate Antigen 19-9 (CA19-9) for Early Mortality in Advanced Pancreatic Cancer.
Usón Junior PLS; Callegaro-Filho D; Bugano DDG; Moura F; Maluf FC
J Gastrointest Cancer; 2018 Dec; 49(4):481-486. PubMed ID: 28924968
[TBL] [Abstract][Full Text] [Related]
10. Factors influencing survival after bypass procedures in patients with advanced pancreatic adenocarcinomas.
Müller MW; Friess H; Köninger J; Martin D; Wente MN; Hinz U; Ceyhan GO; Blaha P; Kleeff J; Büchler MW
Am J Surg; 2008 Feb; 195(2):221-8. PubMed ID: 18154768
[TBL] [Abstract][Full Text] [Related]
11. [Prediction of prognosis of patients with pancreatic adenocarcinoma with curative intent resection by means of histologic grade and pathologic N stage].
Soriano-Izquierdo A; Adet AC; Gallego R; Miquel R; Castells A; Pellisé M; Nadal C; López-Boado MA; Piqué JM; Gascón P; Conill C; Bombí A; Fernández-Cruz L; Maurel J; Navarro S
Med Clin (Barc); 2009 Feb; 132(5):163-71. PubMed ID: 19211081
[TBL] [Abstract][Full Text] [Related]
12. Clinical and pathological features of five-year survivors after pancreatectomy for pancreatic adenocarcinoma.
Kimura K; Amano R; Nakata B; Yamazoe S; Hirata K; Murata A; Miura K; Nishio K; Hirakawa T; Ohira M; Hirakawa K
World J Surg Oncol; 2014 Nov; 12():360. PubMed ID: 25429841
[TBL] [Abstract][Full Text] [Related]
13. Clinical evaluation of CEA, CA19-9, CA72-4 and CA125 in gastric cancer patients with neoadjuvant chemotherapy.
Sun Z; Zhang N
World J Surg Oncol; 2014 Dec; 12():397. PubMed ID: 25543664
[TBL] [Abstract][Full Text] [Related]
14. Stereotactic body radiotherapy using CyberKnife for locally advanced unresectable and metastatic pancreatic cancer.
Su TS; Liang P; Lu HZ; Liang JN; Liu JM; Zhou Y; Gao YC; Tang MY
World J Gastroenterol; 2015 Jul; 21(26):8156-62. PubMed ID: 26185389
[TBL] [Abstract][Full Text] [Related]
15. Tumour cryoablation combined with palliative bypass surgery in the treatment of unresectable pancreatic cancer: a retrospective study of 142 patients.
Li J; Chen X; Yang H; Wang X; Yuan D; Zeng Y; Wen T; Yan L; Li B
Postgrad Med J; 2011 Feb; 87(1024):89-95. PubMed ID: 21131612
[TBL] [Abstract][Full Text] [Related]
16. CEA and CA-19.9 serum tumor markers as prognostic factors in patients with locally advanced (unresectable) or metastatic pancreatic adenocarcinoma: a retrospective analysis.
Tsavaris N; Kosmas C; Papadoniou N; Kopterides P; Tsigritis K; Dokou A; Sarantonis J; Skopelitis H; Tzivras M; Gennatas K; Polyzos A; Papastratis G; Karatzas G; Papalambros A
J Chemother; 2009 Dec; 21(6):673-80. PubMed ID: 20071292
[TBL] [Abstract][Full Text] [Related]
17. Higher overall survival in metastatic pancreatic cancer: the impact of where and how treatment is delivered.
Usón Junior PL; França MS; Rodrigues HV; Macedo AL; Goldenberg A; Smaletz O; Armentano DP; Simon SD; Gansl RC
Einstein (Sao Paulo); 2015; 13(3):347-51. PubMed ID: 26313433
[TBL] [Abstract][Full Text] [Related]
18. Preoperative CEA and CA 19-9 are prognostic markers for survival after curative resection for ductal adenocarcinoma of the pancreas - a retrospective tumor marker prognostic study.
Distler M; Pilarsky E; Kersting S; Grützmann R
Int J Surg; 2013; 11(10):1067-72. PubMed ID: 24161419
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors associated with long-term survival and recurrence in pancreatic adenocarcinoma.
Lee SR; Kim HO; Son BH; Yoo CH; Shin JH
Hepatogastroenterology; 2013; 60(122):358-62. PubMed ID: 23574658
[TBL] [Abstract][Full Text] [Related]
20. Defining optimum treatment of patients with pancreatic adenocarcinoma using regret-based decision curve analysis.
Hernandez JM; Tsalatsanis A; Humphries LA; Miladinovic B; Djulbegovic B; Velanovich V
Ann Surg; 2014 Jun; 259(6):1208-14. PubMed ID: 24169177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
